Fundraising Fox
Amir Nashat
InvestorGeneral Partner at Polaris Entrepreneurs' · Entrepreneur Partner at Polaris Partners
Boston
Writes $300K – $2M checks · typically $500K
Find your path to Amir
Sign up to see every warm intro you have to Amir
- Paths you didn't know you had: your email and LinkedIn already hold routes to Amir. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Amir Nashat is an entrepreneur partner at Polaris Partners in Boston, where he invests in healthcare companies and takes on executive roles inside portfolio companies. He joined the firm in 2002 and serves as a managing partner of Polaris Funds VI through IX. He has repeatedly stepped in as CEO of Polaris-backed startups, including Dewpoint Therapeutics, Jnana, Living Proof, Olivo Labs, Paratus Sciences, and Sun Catalytix, and is currently CEO of Souffle Therapeutics. He earned a doctorate in chemical engineering at MIT under Robert Langer and holds materials science and mechanical engineering degrees from UC Berkeley, and was named to the Forbes Midas List in 2016.
Contact· published on Amir's own website
Invests in
BiotechHealthtech
Beyond investing
- Education
- Completed his ScD in Chemical Engineering with a minor in Biology at MIT under Dr. Robert Langer. Earned both his MS and BS in Materials Science and Mechanical Engineering at UC Berkeley.
- Boards
- Serves on the Partners Innovation Fund and the Investment Advisory Committee for The Engine at MIT. Helped launch the MIT Sandbox Innovation Fund and served as its active president.
- Awards
- Completed his MIT doctorate as a Hertz Fellow. Named to the Forbes Midas List of Top 100 Venture Capitalists in 2016.
From Amir's own website — common ground for a warm intro.
Deals · 15
Morphic Holding, Inc.Board seat
via Polaris Partners · filed Mar 2023 · $100M raise
Camp4 Therapeutics CorpBoard seat
via Polaris Partners · filed Jun 2022
AgbiomeBoard seat
via Polaris Partners · filed Feb 2022 · $117.2M raise
Dewpoint TherapeuticsBoard seat
via Polaris Partners · filed Feb 2022 · $150M raise
Syros Pharmaceuticals, Inc.Board seat
via Polaris Partners · filed Dec 2020 · $121.6M raise
Primmune TherapeuticsBoard seat
via Polaris Partners · filed Nov 2020 · $24M raise
Freenome HoldingsBoard seat
via Polaris Partners · filed Aug 2020 · $270M raise
Cartesian Therapeutics (NASDAQ: RNAC)Board seat
via Polaris Partners · filed Jan 2020 · $70M raise
Scholar Rock Holding Corp, Inc.Board seat
via Polaris Partners · filed Jan 2018 · $47M raise
SofregenBoard seat
via Polaris Partners · filed Sep 2017 · $9.7M raise
MetacrineBoard seat
via Polaris Partners · filed Nov 2016 · $37.8M raise
Fate TherapeuticsBoard seat
via Polaris Partners · filed Aug 2016 · $10.3M raise
1366 TechnologiesBoard seat
via Polaris Partners · filed May 2016 · $30M raise
Scholar RockBoard seat
via Polaris Partners · filed Jan 2016 · $40M raise
aTYR PHARMABoard seat
via Polaris Partners · filed Apr 2015 · $76.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Adnexus TherapeuticsAthenix CorporationAvila TherapeuticsCAMP4 TherapeuticsFreenomeLiving ProofMetacrine TherapeuticsMorphic TherapeuticParatus SciencesPromedior PharmaceuticalsReceptosSelecta BiosciencesSun CatalytixSyros PharmaceuticalsTARIS Biomedical
Investor
AthenixAvila TherapeuticsBIND TherapeuticsFreenomeJnana TherapeuticsKojin TherapeuticsLiving ProofMatter NeuroscienceOlivo Laboratories LLCPervasis TherapeuticsPromediorSelecta BiosciencesSofregen MedicalSouffle TherapeuticsSoufflé TherapeuticsSun Catalytix
Sources: SEC Form D filings · the firm's website · curated public sources.
Colleagues at Polaris Entrepreneurs'
Network6
Investors connected to Amir in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Amir Nashat?
- Amir Nashat is an entrepreneur partner at Polaris Partners in Boston, where he invests in healthcare companies and takes on executive roles inside portfolio companies. He joined the firm in 2002 and serves as a managing partner of Polaris Funds VI through IX. He has repeatedly stepped in as CEO of Polaris-backed startups, including Dewpoint Therapeutics, Jnana, Living Proof, Olivo Labs, Paratus Sciences, and Sun Catalytix, and is currently CEO of Souffle Therapeutics. He earned a doctorate in chemical engineering at MIT under Robert Langer and holds materials science and mechanical engineering degrees from UC Berkeley, and was named to the Forbes Midas List in 2016.
- Where does Amir Nashat work?
- Amir Nashat is General Partner at Polaris Entrepreneurs' and Entrepreneur Partner at Polaris Partners and Entrepreneur Partner at Polaris Partners.
- What does Amir Nashat invest in?
- Amir Nashat invests in Biotech, Healthtech.
- What check size does Amir Nashat write?
- Amir Nashat typically writes checks of $300K – $2M.
- What boards does Amir Nashat sit on?
- Amir Nashat holds tracked board seats at 1366 Technologies, Adnexus Therapeutics, Agbiome, Athenix Corporation, aTYR PHARMA, Avila Therapeutics, CAMP4 Therapeutics, Camp4 Therapeutics Corp, Cartesian Therapeutics (NASDAQ: RNAC), Dewpoint Therapeutics.
- What companies has Amir Nashat invested in?
- Investments tracked here include 1366 Technologies, Agbiome, Athenix, aTYR PHARMA, Avila Therapeutics, BIND Therapeutics, Dewpoint Therapeutics, Fate Therapeutics, Freenome, Jnana Therapeutics, Kojin Therapeutics, Living Proof, and 11 more.
- What awards has Amir Nashat received?
- Completed his MIT doctorate as a Hertz Fellow. Named to the Forbes Midas List of Top 100 Venture Capitalists in 2016.
Founder mafias
Massachusetts Institute of Technology mafia1,487
Also came through, then founded or led a company.
University of California, Berkeley mafia1,343
Also came through, then founded or led a company.
Freenome mafia13
Also came through, then founded or led a company.
Polaris Partners mafia7
Also came through, then founded or led a company.
Polaris Partners mafia6
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Polaris Entrepreneurs''s own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights